GDF15 and atherosclerosis: We demonstrate that in COPD subjects free of clinical CVD, subclinical atherosclerosis (measured as CAC on ungated HRCT) is frequent; and that GDF-15 contributes, independently of common cardiovascular risk factors and measures of COPD severity or phenotype, to its presence and severity.